Incidence and patterns of <it>ALK</it> FISH abnormalities seen in a large unselected series of lung carcinomas
<p>Abstract</p> <p>Background</p> <p>Anaplastic lymphoma receptor tyrosine kinase (<it>ALK</it>) gene rearrangements have been reported in 2-13% of patients with non-small cell lung cancer (NSCLC). Patients with <it>ALK</it> rearrangements do not...
Main Authors: | Dai Zunyan, Kelly JoAnn C, Meloni-Ehrig Aurelia, Slovak Marilyn L, Boles Debra, Christacos Nicole C, Bryke Christine R, Schonberg Steven A, Otani-Rosa Jennifer, Pan Qiulu, Ho Albert K, Sanders Heather R, Zhang Zhong J, Jones Dan, Mowrey Philip N |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Molecular Cytogenetics |
Subjects: | |
Online Access: | http://www.molecularcytogenetics.org/content/5/1/44 |
Similar Items
-
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
by: Chen F, et al.
Published: (2019-05-01) -
Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of <i>ALK</i>-Rearranged NSCLC: <i>ALK</i>- and <i>BRAF</i>-Mutations Followed by Epithelial-Mesenchymal Transition
by: Edyta M. Urbanska, et al.
Published: (2020-04-01) -
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
by: F. Guisier, et al.
Published: (2020-01-01) -
Identification of a novel ALK variant intrinsically resistant to crizotinib
by: Ullas Batra, et al.
Published: (2020-12-01) -
Primary resistance to alectinib in a patient with STRN‐ALK‐positive non‐small cell lung cancer: A case report
by: Kunyan Sun, et al.
Published: (2021-06-01)